Eleonora Sisti

Florence, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Increased CD4/CD8 ratio as a risk factor for critical illness in coronavirus disease 2019 (COVID-19): a retrospective multicentre study.

Increased CD4/CD8 ratio as a risk factor for critical illness in coronavirus disease 2019 (COVID-19): a retrospective multicentre study.

Journal: Infectious diseases (London, England)

Published: June 17, 2020

Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy.

Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy.

Journal: Journal of endocrinological investigation

Published: July 05, 2016

Significance of Low Levels of Thyroglobulin Autoantibodies Associated with Undetectable Thyroglobulin After Thyroidectomy for Differentiated Thyroid Carcinoma.

Significance of Low Levels of Thyroglobulin Autoantibodies Associated with Undetectable Thyroglobulin After Thyroidectomy for Differentiated Thyroid Carcinoma.

Journal: Thyroid : official journal of the American Thyroid Association

Published: March 30, 2016

Acute liver damage following intravenous glucocorticoid treatment for Graves' ophthalmopathy.

Acute liver damage following intravenous glucocorticoid treatment for Graves' ophthalmopathy.

Journal: Endocrine

Published: February 03, 2016

Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy.

Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy.

Journal: Thyroid : official journal of the American Thyroid Association

Published: June 20, 2015

Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological study.

Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological study.

Journal: European journal of endocrinology

Published: February 10, 2015

Role of the underlying thyroid disease on the phenotype of Graves' orbitopathy in a tertiary referral center.

Role of the underlying thyroid disease on the phenotype of Graves' orbitopathy in a tertiary referral center.

Journal: Thyroid : official journal of the American Thyroid Association

Published: January 14, 2015

Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy.

Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy.

Journal: Journal of endocrinological investigation

Published: December 15, 2014

Spontaneous improvement of untreated mild Graves' ophthalmopathy: Rundle's curve revisited.

Spontaneous improvement of untreated mild Graves' ophthalmopathy: Rundle's curve revisited.

Journal: Thyroid : official journal of the American Thyroid Association

Published: August 29, 2013

Thyroid volume and severity of Graves' orbitopathy.

Thyroid volume and severity of Graves' orbitopathy.

Journal: Thyroid : official journal of the American Thyroid Association

Published: October 24, 2012

Enalapril reduces proliferation and hyaluronic acid release in orbital fibroblasts.

Enalapril reduces proliferation and hyaluronic acid release in orbital fibroblasts.

Journal: Thyroid : official journal of the American Thyroid Association

Published: October 04, 2012

Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies.

Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies.

Journal: The Journal of clinical endocrinology and metabolism

Published: September 06, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026